Cargando…

K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review

SIMPLE SUMMARY: The cancer associated protein BRCA2 is the subject of intense continual study. Because of this, new insights into the relation of specific variants of this gene and cancer are regularly generated. These discoveries shed light on cancer risk and management for patients carrying these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baughan, Scott, Tainsky, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865497/ https://www.ncbi.nlm.nih.gov/pubmed/33503928 http://dx.doi.org/10.3390/cancers13030447

Ejemplares similares

Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context
por: Thompson, Ella R., et al.
Publicado: (2015)

A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers
por: Zamani, Neda, et al.
Publicado: (2023)

Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
por: Piombino, Claudia, et al.
Publicado: (2020)

Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
por: Digennaro, M., et al.
Publicado: (2017)

Functional and Structural Analysis of C-Terminal BRCA1 Missense Variants
por: Quiles, Francisco, et al.
Publicado: (2013)

Application of Multilayer Evidence for Annotation of C-Terminal BRCA2 Variants
por: Butz, Henriett, et al.
Publicado: (2021)

Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in BRCA and in Other Susceptibility Genes
por: D’Elia, Giovanna, et al.
Publicado: (2022)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Ewald, Ingrid Petroni, et al.
Publicado: (2016)

Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndrome
por: Minucci, Angelo, et al.
Publicado: (2018)

Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer
por: Liu, Yaxuan, et al.
Publicado: (2022)

Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
por: Sukumar, Jasmine, et al.
Publicado: (2021)

3326 Radiofrequency Renal Denervation Prevents Further Progression of Hypertension and Decreases Renal Medullary Fibrosis in One-year-old Spontaneously Hypertensive Rats (SHR)
por: Gao, Juan, et al.
Publicado: (2019)

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases
por: Caputo, Sandrine, et al.
Publicado: (2012)

Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients
por: Jarhelle, Elisabeth, et al.
Publicado: (2019)

Other cancers in BRCA1 and BRCA2 mutation carriers: implications for counselling and follow up
por: Ponder, B
Publicado: (2000)

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
por: Osman, K., et al.
Publicado: (2023)

Erratum. Association Between Long-term Exposure to Air Pollution and Biomarkers Related to Insulin Resistance, Subclinical Inflammation, and Adipokines. Diabetes 2016;65:3314–3326
por: Wolf, Kathrin, et al.
Publicado: (2017)

Genetic Variants in the 3’UTR of BRCA1 and BRCA2 Genes and Their Putative Effects on the microRNA Mechanism in Hereditary Breast and Ovarian Cancer
por: Sánchez-Chaparro, María Marisela, et al.
Publicado: (2020)

Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2
por: Samuel, David, et al.
Publicado: (2022)

The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability
por: Arason, Adalgeir, et al.
Publicado: (2019)

Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
por: Kim, Joo Heung, et al.
Publicado: (2021)

BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome
por: Le, Trong-Nhan N., et al.
Publicado: (2022)

Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay
por: Nepomuceno, Thales C., et al.
Publicado: (2022)

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control
por: Janavičius, Ramūnas
Publicado: (2010)

BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories
por: Hovland, Henrikke N., et al.
Publicado: (2022)

Probing Structure-Function Relationships in Missense Variants in the Carboxy-Terminal Region of BRCA1
por: Carvalho, Renato S., et al.
Publicado: (2014)

Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families
por: Kaplun, Ludmila, et al.
Publicado: (2012)

Identification of the c.829_832delAATA Deletion Variants in the BRCA1 Gene Associated with Hereditary Breast/Ovarian Cancer ˗ Case Report
por: Ostrowska, Malgorzata, et al.
Publicado: (2022)

Dual BRCA1 and BRCA2 pathogenic variants in an adolescent with syndromic intellectual disability
por: Algouneh, Arash, et al.
Publicado: (2022)

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
por: Ewald, Ingrid P, et al.
Publicado: (2011)

Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer
por: Wappenschmidt, B, et al.
Publicado: (2005)

Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation
por: Ribeiro Guerra, Maximiliano, et al.
Publicado: (2021)

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
por: NOVAKOVIĆ, SRDJAN, et al.
Publicado: (2012)

Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer
por: Buleje, Jose, et al.
Publicado: (2017)

Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes
por: Toss, Angela, et al.
Publicado: (2015)

BRCA2 c.8827C>T pathogenic mutation in a consanguineous Chinese family with hereditary breast cancer
por: Wang, Jiangfen, et al.
Publicado: (2020)

Hereditary breast cancer – a spectrum of pathogenic mutations and unknown variants of BRCA1 and BRCA2 genes in the Czech Republic: efficiency of testing and clinical follow-up
por: Foretova, L, et al.
Publicado: (2005)

Novel BRCA2 pathogenic variant c.5219 T > G; p.(Leu1740Ter) in a consanguineous Senegalese family with hereditary breast cancer
por: Diop, Jean Pascal Demba, et al.
Publicado: (2019)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ll6r0vapprld0rkcf0rui6j78u